SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001735276-19-000015
Filing Date
2019-01-11
Accepted
2019-01-11 16:06:26
Documents
2
Period of Report
2019-01-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 3  
1 PRIMARY DOCUMENT edgardoc.xml 3 1465
2 EDGAR SUPPORTING DOCUMENT hamburg_101018poa.txt EX-24 3984
  Complete submission text file 0001735276-19-000015.txt   6862
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Issuer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O HENRY SCHEIN INC 135 DORYER ROAD MELVILLE NY 11747
Business Address
HAMBURG MARGARET A (Reporting) CIK: 0001266917 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36407 | Film No.: 19522422